Abstract |
The survival of 90% of a tumor-bearing population treated with the complex Rh(2) (CF(3)CONH)(4) was examined and the pharmacological parameter Surv(90) determined. Histopathological alterations raised for this drug in several tissues were studied in Balb-c mice. A Surv(90) dose of 3.8x 10(-5) mol/kg was found.
|
Authors | B P Espósito, S B Zyngier, R Najjar, R P Paes, S M Ueda, J C Barros |
Journal | Metal-based drugs
(Met Based Drugs)
Vol. 6
Issue 1
Pg. 17-8
( 1999)
ISSN: 0793-0291 [Print] United States |
PMID | 18475875
(Publication Type: Journal Article)
|